SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-004469
Filing Date
2022-02-14
Accepted
2022-02-14 16:31:30
Documents
89
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1935399
2 form10-k001.jpg GRAPHIC 37712
3 ex3-13.htm EX-3.13 11929
4 ex4-7.htm EX-4.7 20669
5 ex23-1.htm EX-23.1 4923
6 ex31-1.htm EX-31.1 20478
7 ex31-2.htm EX-31.2 20389
8 ex32-1.htm EX-32.1 6603
9 ex32-2.htm EX-32.2 6769
  Complete submission text file 0001493152-22-004469.txt   7940525

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE adxs-20211031.xsd EX-101.SCH 55813
11 XBRL CALCULATION FILE adxs-20211031_cal.xml EX-101.CAL 76407
12 XBRL DEFINITION FILE adxs-20211031_def.xml EX-101.DEF 243948
13 XBRL LABEL FILE adxs-20211031_lab.xml EX-101.LAB 485893
14 XBRL PRESENTATION FILE adxs-20211031_pre.xml EX-101.PRE 401110
83 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1035825
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-36138 | Film No.: 22632992
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences